Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biogen CMO joins Flex Pharma's SAB

This article was originally published in Scrip

Executive Summary

Flex Pharma, a biotechnology company developing innovative treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions, has named Dr Alfred Sandrock Jr, current chief medical officer of Biogen, to its scientific advisory board. Dr Sandrock Jr is Biogen's group senior vice-president of development sciences and CMO. But since joining Biogen in 1998, he has held several senior executive positions, including senior vice-president of development sciences, senior vice-president of neurology R&D, and vice-president of clinical development, neurology.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC029011

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel